跳至主要内容
临床试验/NL-OMON41181
NL-OMON41181尚未招募不适用

Sentinel node biopsy for bladder cancer using the hybrid tracer - Hybrid sentinel node biopsy for bladder cancer

eids Universitair Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients >18 years with clinically localized bladder cancer
  • Patients with proven histological-pathological bladder cancer
  • Patients scheduled for brachytherapy or radical cystectomy with or without neo-adjuvant chemotherapy
  • Patients with cN0 lymph node status

排除标准

  • Patients with preoperatively known distant metastases (M1);
  • Patients with clinically tumor positive nodes;
  • Previous radiation therapy of the pelvis;
  • Previous pelvic lymphadenectomy for other reasons such as urologic and gynecologic malignancies

研究者

相似试验